Clearside Biomedical, Inc. (CLSD) Social Stream
Clearside Biomedical Inc (CLSD) Price Targets From Analysts
Use the tables below to see what analysts covering Clearside Biomedical Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 46 weeks, CLSD's average price target has gone up $4.42.
Over the past 49 weeks, CLSD's average upside potential has been 163.68%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CLSD Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 151 days, CLSD's average broker recommendation rating improved by 0.6.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, Clearside Biomedical Inc's upside potential (average analyst target price relative to current price) is greater than 376.87% of them.
- CLSD has a lower variance in analysts' estimates than -270.75% of all US stocks.
- In terms of how Clearside Biomedical Inc fares relative to all US stocks, note that its average analyst price target is greater than 40.45% of that group.
- To contextualize these metrics, consider that out of Healthcare stocks, Clearside Biomedical Inc's number of analysts covering the stock is higher than 133.09% of them.
In the Pharmaceutical Products industry, CLNN, CKPT, and CINC are the three stocks most similar to Clearside Biomedical Inc regarding the price target and analyst recommendation information presented here.
What is the outlook for CLSD? Use POWR Ratings for clearer insight into price direction.